Ironwood Pharmaceuticals, Inc. - (IRWD): Price and Financial Metrics


Ironwood Pharmaceuticals, Inc. - (IRWD): $13.34

-0.15 (-1.11%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

IRWD POWR Grades


  • IRWD scores best on the Value dimension, with a Value rank ahead of 98.23% of US stocks.
  • IRWD's strongest trending metric is Momentum; it's been moving down over the last 48 weeks.
  • IRWD ranks lowest in Momentum; there it ranks in the 5th percentile.

IRWD Stock Summary

  • IRWD's current price/earnings ratio is 4.16, which is higher than just 3.95% of US stocks with positive earnings.
  • IRWD's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of 72.07% of US stocks.
  • As for revenue growth, note that IRWD's revenue has grown -3.24% over the past 12 months; that beats the revenue growth of merely 24.96% of US companies in our set.
  • Stocks that are quantitatively similar to IRWD, based on their financial statements, market capitalization, and price volatility, are GKOS, MITK, NOVT, TUFN, and NBIX.
  • Visit IRWD's SEC page to see the company's official filings. To visit the company's web site, go to www.ironwoodpharma.com.

IRWD Valuation Summary

  • In comparison to the median Healthcare stock, IRWD's price/sales ratio is 36.84% higher, now standing at 5.2.
  • Over the past 141 months, IRWD's EV/EBIT ratio has gone up 24.6.
  • Over the past 141 months, IRWD's EV/EBIT ratio has gone up 24.6.

Below are key valuation metrics over time for IRWD.

Stock Date P/S P/B P/E EV/EBIT
IRWD 2021-08-31 5.2 4.2 4.2 10.3
IRWD 2021-08-30 5.2 4.2 4.3 10.4
IRWD 2021-08-27 5.2 4.2 4.2 10.4
IRWD 2021-08-26 5.2 4.2 4.2 10.3
IRWD 2021-08-25 5.2 4.2 4.2 10.3
IRWD 2021-08-24 5.2 4.2 4.2 10.4

IRWD Growth Metrics

  • Its 5 year cash and equivalents growth rate is now at -9.51%.
  • Its 4 year net cashflow from operations growth rate is now at 236.25%.
  • The year over year price growth rate now stands at 0.87%.
IRWD's revenue has moved up $278,703,000 over the prior 70 months.

The table below shows IRWD's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 413.024 227.407 508.856
2021-03-31 398.425 198.927 142.757
2020-12-31 389.523 168.836 106.176
2020-09-30 399.144 144.903 110.83
2020-06-30 426.843 126.038 97.055
2020-03-31 439.626 96.713 84.134

IRWD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • IRWD has a Quality Grade of B, ranking ahead of 94.85% of graded US stocks.
  • IRWD's asset turnover comes in at 0.622 -- ranking 50th of 677 Pharmaceutical Products stocks.
  • LGND, IBIO, and COLL are the stocks whose asset turnover ratios are most correlated with IRWD.

The table below shows IRWD's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.622 0.998 0.305
2021-03-31 0.761 0.998 0.286
2020-12-31 0.820 0.992 0.226
2020-09-30 0.916 0.967 0.230
2020-06-30 1.077 0.976 0.213
2020-03-31 1.207 0.951 0.198

IRWD Price Target

For more insight on analysts targets of IRWD, see our IRWD price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $13.83 Average Broker Recommendation 1.71 (Moderate Buy)

IRWD Stock Price Chart Interactive Chart >

Price chart for IRWD

IRWD Price/Volume Stats

Current price $13.34 52-week high $14.27
Prev. close $13.49 52-week low $8.63
Day low $13.26 Volume 513,566
Day high $13.53 Avg. volume 1,934,998
50-day MA $13.02 Dividend yield N/A
200-day MA $11.66 Market Cap 2.17B

Ironwood Pharmaceuticals, Inc. - (IRWD) Company Bio


Ironwood Pharmaceuticals engages in the research, development, and commercialization of human therapeutic products, with a key focus being the treatment of adult men and women suffering from irritable bowel syndrome. The company was founded in 1998 and is based in Cambridge, Massachusetts.


IRWD Latest News Stream


Event/Time News Detail
Loading, please wait...

IRWD Latest Social Stream


Loading social stream, please wait...

View Full IRWD Social Stream

Latest IRWD News From Around the Web

Below are the latest news stories about Ironwood Pharmaceuticals Inc that investors may wish to consider to help them evaluate IRWD as an investment opportunity.

Top Pharmaceutical Stocks for Q4 2021

These are the pharmaceutical stocks with the best value, fastest growth, and most momentum for Q4 2021.

Yahoo | September 14, 2021

Citius (CTXR) Acquires Dr. Reddy's License for NHL Therapy

Citius Pharmaceuticals (CTXR) acquires Dr. Reddy's exclusive license rights for E7777 to treat a rare form of NHL and other cancer indications.

Yahoo | September 8, 2021

Takeda (TAK) Hematology Candidate Fails in Late-Stage Study

Takeda's (TAK) pipeline candidate, pevonedistat, fails to achieve statistically significant event-free survival in patients with hematological disorders.

Yahoo | September 3, 2021

Ironwood Pharmaceuticals to Participate in Upcoming September Investor Conferences

BOSTON, September 02, 2021--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will participate in fireside chats at two upcoming virtual investor conferences in September:

Yahoo | September 2, 2021

Amneal (AMRX) Parkinson's Candidate Successful in Pivotal Study

Amneal's (AMRX) IPX-203 increases "Good On" time by 1.55 hours per dose versus immediate-release CD/LD in patients with Parkinson's disease.

Yahoo | August 26, 2021

Read More 'IRWD' Stories Here

IRWD Price Returns

1-mo 0.91%
3-mo 3.65%
6-mo 22.61%
1-year 39.98%
3-year -27.74%
5-year -13.38%
YTD 17.12%
2020 -14.43%
2019 28.47%
2018 -30.89%
2017 -1.96%
2016 31.92%

Continue Researching IRWD

Here are a few links from around the web to help you further your research on Ironwood Pharmaceuticals Inc's stock as an investment opportunity:

Ironwood Pharmaceuticals Inc (IRWD) Stock Price | Nasdaq
Ironwood Pharmaceuticals Inc (IRWD) Stock Quote, History and News - Yahoo Finance
Ironwood Pharmaceuticals Inc (IRWD) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 1.133 seconds.